Rocket Lab Corporation (RKLB) said the inaugural launch of its Neutron rocket is now expected in 2027, shifting the target into next year. The company said its team continues development and incorporates process improvements while progressing through key manufacturing and testing milestones.
Rocket Lab issued a press release and made an accompanying presentation available with further details on the Neutron update. It said it will provide additional updates as work continues.
Rocket Lab Corp Chief Financial Officer Adam C. Spice exercised options for 140,157 common shares at $1.09 per share on October 1, 2026, and sold 140,157 shares that day in three tranches: 39,669 at a weighted-average $70.2827, 85,288 at $70.8922, and 15,200 at $71.7862 per share. The sales occurred automatically under a Rule 10b5-1 trading plan adopted June 3, 2026. After the exercise, his direct option holdings were 2,242,511 shares; reported indirect holdings included 250,000 common shares held by a trust.
Rocket Lab Corp. (RKLB) officer Adam Clark Spice gave notice of a proposed sale of 140,157 common shares, with a reported aggregate market value of $9,766,139.76 and an approximate sale date of October 1, 2026. The shares are listed as acquired from the issuer through stock-option exercise for cash. Morgan Stanley Smith Barney LLC is named in the broker information.
Rocket Lab Corporation (RKLB) reports updates to the financing of its pending acquisition of Iridium Communications. Iridium’s lenders have entered into a Consent and Amendment that treats the transaction as not a change of control, expressly consents to the deal, and will add a Rocket Lab USA, Inc. guarantee and higher interest margins, exit fees and prepayment premiums after closing. Rocket Lab also terminated a previously arranged $3.6 billion bridge loan commitment and instead has raised approximately $1.944 billion in gross proceeds through the sale of about 29.3 million shares under an at-the-market equity program, which, together with Iridium term loans and other funding sources, is stated to be sufficient to cover anticipated cash payments for completing the Iridium acquisition.
Rocket Lab Corporation (RKLB) reported that it has fully arranged financing for its pending acquisition of Iridium Communications Inc. through a completed equity program and amended term debt at Iridium. The company raised approximately $1.944 billion in gross proceeds via its At-The-Market share sale, issuing 29.3 million shares, and intends to use the net proceeds primarily to fund cash payments under the Iridium acquisition.
Iridium’s existing term loan facility, covering $1.775 billion of term loans, was amended so Rocket Lab’s acquisition will not be treated as a change of control, allowing the loans to remain outstanding after closing. Upon completion of the transaction, Rocket Lab USA, Inc. will provide an unsecured guarantee of the Iridium term loan, and interest margins will increase within stated ranges, with a 1.00% exit fee on certain prepayments and a 1.00% prepayment premium in repricing transactions. With the amended Iridium term loan, ATM proceeds and other available cash, Rocket Lab states it has sufficient funds to cover required cash consideration, certain Iridium debt repayments and related expenses, and has terminated its prior $3.6 billion senior secured bridge loan commitment. The Iridium acquisition is described as expected to close in mid‑2027.
Rocket Lab Corp (RKLB) reported that Chief Financial Officer Adam C. Spice exercised employee stock options and sold common shares on September 2, 2026. He exercised options for 140,157 shares of common stock at an exercise price of $1.09 per share, then sold the same number of shares in open-market transactions under a Rule 10b5-1 trading plan adopted on June 3, 2026.
The sales comprised 67,257 shares at a weighted-average price of about $62.26 per share within a range of $61.59 to $62.58, and 72,900 shares at a weighted-average price of about $62.97 per share within a range of $62.59 to $63.47. Following the option exercise, Spice held 2,382,668 stock options, and a separate trust associated with him held 250,000 shares of common stock indirectly.
Rocket Lab Corp (RKLB) director Merline Saintil reported a bona fide gift of 261,903 shares of common stock on August 31, 2026, transferring them without consideration to her revocable living trust for estate planning purposes. She now holds 2,482 shares directly and 261,903 shares indirectly through the trust, retaining an indirect pecuniary interest in those trust-held shares. No Rule 10b5-1 trading plan is reported.
Rocket Lab Corp (RKLB) received a Form 144 notice from officer Adam C. Spice indicating an intention to sell up to 140,157 shares of common stock through Morgan Stanley Smith Barney, following an acquisition of these shares via exercise of stock options for cash on September 2, 2026. The securities section lists an aggregate market value of $8,765,418.78 for the shares and cites 598,350,482 shares as a reference outstanding figure. The filing also reports prior sales of Rocket Lab common stock by Spice over the past three months.
Rocket Lab Corp (RKLB) reported that Chief Operations Officer Frank Klein sold a total of 35,558 shares of common stock on August 27, 2026, in three open-market transactions at weighted-average prices of $66.2510, $66.8576, and $67.5387. All sales were made pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2025, and were executed in multiple trades within disclosed price ranges.
Rocket Lab Corp (RKLB) insider Arjun Kampani, SVP & General Counsel, reported selling a total of 6,034 shares of common stock on August 27, 2026 under a Rule 10b5-1 trading plan. The sales were executed in two tranches at weighted-average prices within disclosed intraday ranges.